研究実績  |  RESULTS ACHIEVEMENT

英文論文

    2020
  • Nakano T, Inoue I, Takenaka Y, Ito R, Kotani N, Sato S, Nakano Y, Hirasaki M, Shimada A, Murakoshi T. Ezetimibe impairs transcellular lipid trafficking and induces large lipid droplet formation in intestinal absorptive epithelial cells. Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Dec;1865(12):158808.

  • 2020
  • Wilunda C, Sawada N, Goto A, Yamaji T, Iwasaki M, Tsugane S, Noda M. Soy food and isoflavones are not associated with changes in serum lipids and glycohemoglobin concentrations among Japanese adults: a cohort study. Eur J Nutr. 2020 Aug;59(5):2075-2087.

  • 2020
  • Kikuchi H, Inoue S, Odagiri Y, Ihira H, Inoue M, Sawada N, Noda M, Tsugane S. Intensity-specific validity and reliability of the Japan Public Health Center-based prospective study-physical activity questionnaire.  Prev Med Rep. 2020 Aug 6;20:101169. 

  • 2020
  • Saito D, Nakajima R, Yasuda S. Examination of Malignant Findings of Thyroid Nodules Using Thyroid Ultrasonography. J Clin Med Res. 2020;12(8):499-507.

  • 2020
  • Isshiki M, Sakuma I, Hayashino Y, Sumita T, Hara K, Takahashi K, Shiojima I, Satoh-Asahara N, Kitazato H, Ito D, Saito D, Hatano M, Ikegami Y, Iida S, Shimada A, Noda M. Effects of dapagliflozin on renin-angiotensin-aldosterone system under renin-angiotensin system inhibitor administration. Endocr J. 2020 Nov 28;67(11):1127-1138.

  • 2020
  • Yamazaki C, Goto A, Iwasaki M, Sawada N, Oba S, Noda M, Iso H, Koyama H, Tsugane S. Body mass index and mortality among middle-aged Japanese individuals with diagnosed diabetes: The Japan Public Health Center-based prospective study (JPHC study).  Diabetes Res Clin Pract. 2020 Jun;164:108198.

  • 2020
  • Koba S, Inoue I, Cyrille M, Lu C, Inomata H, Shimauchi J, Kajinami K. Evolocumab vs. Ezetimibe in Statin-Intolerant Hyperlipidemic Japanese Patients: Phase 3 GAUSS-4 Trial. J Atheroscler Thromb. 2020 May 1;27(5):471-484.

  • 2020
  • Yamamoto J, Ishihara J, Kotemori A, Yoshizaki T, Goto A, Mizoue T, Noda M, Sawada N, Tsugane S. Association between Okinawan vegetables consumption and risk of type 2 diabetes in Japanese communities: The JPHC Study. J Epidemiol. 2020 May 5;30(5):227-235.

  • 2020
  • Akter S, Kuwahara K, Matsushita Y, Nakagawa T, Konishi M, Honda T, Yamamoto S, Hayashi T, Noda M, Mizoue T; Japan Public Health Center-based Prospective Study Group. Serum 25-hydroxyvitamin D3 and risk of type 2 diabetes among Japanese adults: the Hitachi Health Study. Clin Nutr. 2020 Apr;39(4):1218-1224.

  • 2020
  • Kawasaki E, Oikawa Y, Okada A, Kanatsuna N, Kawamura T, Kikuchi T, Terasaki J, Miura J, Ito Y, Hanafusa T. Zinc transporter 8 autoantibodies complement glutamic acid decarboxylase and insulinoma-associated antigen-2 autoantibodies in the identification and characterization of Japanese type 1 diabetes. J Diabetes Investig. 2020 Sep;11(5):1181-1187.

  • 2020
  • Kajinami K, Tsukamoto K, Koba S, Inoue I, Yamakawa M, Suzuki S, Hamano T, Saito H, Saito Y, Masuda S, Nakayama T, Okamura T, Yamashita S, Kagawa T, Kaneyama J, Kuriyama A, Tanaka R, Hirata A; Statin Intolerance Clinical Guide Working Group; The Japan Society of Hepatology, Japanese Society of Neurology, Japan Atherosclerosis Society, The Japanese Society for the Study of Xenobiotics. Statin Intolerance Clinical Guide 2018. J Atheroscler Thromb. 2020 Apr 1;27(4):375-396.

  • 2020
  • Satomura A, Oikawa Y, Haisa A, Inoue I, Noda M, Shimada A. Bodyweight threshold for sudden onset of ketosis might exist in ketosis-prone type 2 diabetes patients. J Diabetes Investig. 2020 Mar; 11(2): 499–501.

  • 2020
  • Inoue I, Takenaka Y, Kin Y, Yamazaki S, Ikegami Y, Saito D, Shimada A. A sudden onset of severe thrombocytopenia while using evolocumab. Case Rep Hematol. 2020 Mar 26;2020:3281626.

  • 2020
  • Goto A, Yamaji T, Sawada N, Momozawa Y, Kamatani Y, Kubo M, Shimazu T, Inoue M, Noda M, Tsugane S, Iwasaki M. Diabetes and cancer risk: A Mendelian randomization study. Int J Cancer. 2020 Feb 1;146(3):712-719. 

  • 2020
  • Yasuda S, Hikima Y, Kabeya Y, Iida S, Oikawa Y, Isshiki M, Inoue I, Shimada A, Noda M. Clinical characterization of patients with primary aldosteronism plus subclinical Cushing’s syndrome. BMC Endocr Disord. 2020 Jan 13;20(1):9

  • 2020
  • Kurihara S, Oikawa Y, Nakajima R, Satomura A, Tanaka R, Kagamu H, Shimada A. Simultaneous Development of Graves’ Disease and Type 1 Diabetes during Anti-programmed Cell Death-1 Therapy: A Case Report. J Diabetes Investig2020 Jan 11;11(4):1006-1009.

  • 2020
  • Fuchigami A, Shigiyama F, Kitazawa T, Okada Y, Ichijo T, Higa M, Hiyoshi T, Inoue I, Iso K, Yoshii H, Hirose T, Kumashiro N. Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR). Cardiovasc Diabetol. 2020 Jan 7;19(1):1. 

  • 2019
  • Hatano M, Inoue I, Kurihara S, Ono H, Matsuda M, Kakei M, Inukai T, Aso Y, Katayama S. Long-Term Efficacy and Safety of Add-On Therapy of Sitagliptin to a Very Small Dose of Glimepiride Versus a Small Dose of Glimepiride Over Eighteen Months. J Endocrinol Metab. 2019 Dec;9(6):171-179.

  • 2019
  • Kashino I, Serafini M, Kurotani K, Akter S, Mizoue T, Ishihara J, Kotemori A, Sawada N, Inoue M, Iwasaki M, Noda M, Tsugane S; Japan Public Health Center-based Prospective Study Group. Relationship between dietary non-enzymatic antioxidant capacity and type 2 diabetes risk in the Japan Public Health Center-based Prospective Study. Nutrition. 2019 Oct;66:62-69. 

  • 2019
  • Oikawa Y, Sakamoto K, Satomura A, Haisa A, Katsuki T, Hattori Y, Inoue I, Noda M, Shimada A. Significance of peripheral mononuclear cells producing interferon-γ in response to insulin B:9–23-related peptides in subtypes of type 1 diabetes. Clin Immunol. 2019 Nov;208:108260.

  • 2019
  • Kashino I, Mizoue T, Serafini M, Akter S, Sawada N, Ishihara J, Kotemori A, Inoue M, Yamaji T, Goto A, Iwasaki M, Noda M, Tsugane S; Japan Public Health Center-based Prospective Study Group. Higher Dietary Non-enzymatic Antioxidant Capacity Is Associated with Decreased Risk of All-Cause and Cardiovascular Disease Mortality in Japanese Adults. J Nutr. 2019 Sep 9:nxz145.

  • 2019
  • Hatano M, Mimura T, Shimada A, Noda M, Katayama S. Hepatitis B virus reactivation with corticosteroid therapy in patients with adrenal insufficiency. Endocrinology, Diabetes & Metabolism. 2019 May 9;2(3):e00071.

  • 2019
  • Nakamura Y, Nagai Y, Kobayashi T, Furukawa K, Oikawa Y, Shimada A, Tanaka Y. Characteristics of Gut Microbiota in Patients With Diabetes Determined by Data Mining Analysis of Terminal Restriction Fragment Length Polymorphisms. J Clin Med Res. 2019 Jun;11(6):401-406

  • 2019
  • Katanoda K, Noda M, Goto A, Mizunuma H, Lee JS, Hayashi K. Being underweight in adolescence is independently associated with adult-onset diabetes among women: The Japan Nurses’ Health Study. J Diabetes Investig. 2019 May;10(3):827-836.

  • 2019
  • Nakashima N, Noda M, Ueki K, Koga T, Hayashi M, Yamazaki K, Nakagami T, Ohara M, Gochi A, Matsumura Y, Kimura M, Ohe K, Kang D, Toya Y, Yamagata K, Yokote K, Ikeda S, Mitsutake N, Yamamoto R, Tanizawa Y. Recommended configuration for personal health records by standardized data item sets for diabetes mellitus and associated chronic diseases: A report from Collaborative Initiative by six Japanese Associations. J Diabetes Investig. 2019 May;10(3):868-875. 

  • 2019
  • Chen S, Akter S, Kuwahara K, Matsushita Y, Nakagawa T, Konishi M, Honda T, Yamamoto S, Hayashi T, Noda M, Mizoue T. Serum amino acid profiles and risk of type 2 diabetes among Japanese adults in the Hitachi Health Study. Sci Rep. 2019 May 7;9(1):7010. 

  • 2019
  • Sakane N, Kotani K, Suganuma A, Takahashi K, Sato J, Suzuki S, Izumi K, Kato M, Noda M, Nirengi S, Kuzuya H. Prevention of Metabolic Syndrome by Telephone-Delivered Lifestyle Intervention in a Real-World Setting: Sub-Analysis of a Cluster-Randomized Trial. Metab Syndr Relat Disord. 2019 Sep;17(7):355-361.

  • 2019
  • Nakashima N, Noda M, Ueki K, Koga T, Hayashi M, Yamazaki K, Nakagami T, Ohara M, Gochi A, Matsumura Y, Kimura M, Ohe K, Kang D, Toya Y, Yamagata K, Yokote K, Ikeda S, Mitsutake N, Yamamoto R, Tanizawa Y. Recommended configuration for personal health records by standardized data item sets for diabetes mellitus and associated chronic diseases: a report from a collaborative initiative by six Japanese associations. Diabetol Int. 2019 Apr 25;10(2):85-92. 

  • 2019
  • Goto A, Yamaji T, Sawada N, Momozawa Y, Kamatani Y, Kubo M, Shimazu T, Inoue M, Noda M, Tsugane S, Iwasaki M. Diabetes and cancer risk: A Mendelian randomization study. Int J Cancer. 2020 Feb 1;146(3):712-719. 

  • 2019
  • Oikawa Y, Kondo T, Shimada A, Seino Y, Kitaoka M: Actual condition survey regarding mismatch of measurements between radioimmunoassay and enzyme-linked immunosorbent assay tests for anti-glutamic acid decarboxylase antibody in real-world clinical practice. J Diabetes Investig. 2019 May;10(3):685-689.

  • 2019
  • Saito D, Oikawa Y, Yano Y, Ikegami Y, Satomura A, Isshiki M, Kurihara S, Inoue I, Noda M, Shimada A. Detailed Time Course of Decline in Serum C-Peptide Levels in Anti-Programmed Cell Death-1 Therapy-Induced Fulminant Type 1 Diabetes. Diabetes Care. 2019 Mar;42(3):e40-e41.

ACCESSご案内

埼玉医科大学

埼玉医科大学病院

〒350-0495 埼玉県入間郡毛呂山町毛呂本郷38
TEL: 049-276-1111(代)
FAX: 049-294-9752

お車をご利用される方
鶴ヶ島インターから約10km(約20~30分)
詳しくはこちら

電車・バスをご利用される方
池袋駅より東毛呂駅まで約1時間
東毛呂駅からバス(約5分)もしくは徒歩(約20分)
詳しくはこちら

本フォームは医療従事者専用となっております。ご病状やお薬、検査、予約など診療に関する患者さんからのご相談は、法律上、一切お受けすることができません。ご理解のほどよろしくお願いいたします。